Latest News about IMCR
Recent news which mentions IMCR
   After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
   
  
  
  November 18, 2022
  From Benzinga
 
   What 6 Analyst Ratings Have To Say About Immunocore Hldgs
   
  October 13, 2022
  Tickers 
   IMCR
  
  
  From Benzinga
 
   Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
   
  
  
  September 12, 2022
  From Benzinga
 
   Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
   
  
  
  September 09, 2022
  From Benzinga
 
   Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%
   
  
  
  September 09, 2022
  From Benzinga
 
   Immunocore Shares Fall After Early Solid Cancer Trial Data Of TCR Therapy
   
  September 09, 2022
  Tickers 
   IMCR
  
  
  From Benzinga
 
   Why Zscaler Is Trading Higher By Around 19%, Here Are 44 Stocks Moving In Friday's Mid-Day Session
   
  
  
  September 09, 2022
  From Benzinga
 
   Nasdaq Jumps Over 200 Points, Crude Oil Rises Sharply
   
  
  
  September 09, 2022
  From Benzinga
 
   Enphase Energy, Immunocore And Some Other Big Stocks Moving Lower On Friday
   
  
  
  September 09, 2022
  From Benzinga
 
   US Stocks Open Higher, Dow Surges 300 Points
   
  
  
  September 09, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
   
  
  
  September 09, 2022
  From Benzinga
 
   Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
   
  
  
  September 09, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
   
  
  
  September 08, 2022
  From Benzinga
 
   Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday
   
  
  
  September 06, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
   
  
  
  August 08, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
   
  
  
  August 02, 2022
  From Benzinga
 From Benzinga
 
   What's Winning in 2022? 3 Stocks That Are Doing Fine
   
  
  
  July 16, 2022
  From Motley Fool
 From Benzinga
 From Motley Fool
 From Motley Fool
 
   Immunocore Eye Cancer Cell Therapy Scores European Approval
   
  April 04, 2022
  Tickers 
   IMCR
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

